Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ff562271e48826aa3345651d6edda18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6029531b61a31068fc51aead341dd55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_742cf23c579485a3a2594da198fe275c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd0c528fb4bc216a54b2db1d265c03a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a499effa2992e3750e1d3a421301c58c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99522c0db54484c7e5a9e9deb977be87 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
filingDate |
2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc112c65565156be6eca6f55b2aef845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e41a911f3fe3cba3179977c1211f6475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f57eb2b59aee0bacdb5690ef822d5ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801b0aa61c84e913054b5c656ed9f766 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f33d591c86ecc65be98571a9478bc68 |
publicationDate |
2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012095820-A1 |
titleOfInvention |
Use of simalikalactone e as an anticancer agent |
abstract |
The invention relates to Simalikalactone E (SkE) to be used for preventing and/or treating cancers. |
priorityDate |
2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |